X
ELV icon

Xponance’s Elevance Health ELV Stock Holding History

Xponance’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$16M Sell
41,309
-209
-0.5% -$77.5K 0.1% 166
2026
Q1 		$12.2M Buy
41,518
+5,200
+14% +$1.71M 0.09% 193
2025
Q4 		$12.7M Buy
36,318
+1,533
+4% +$518K 0.1% 166
2025
Q3 		$11.2M Sell
34,785
-1,241
-3% -$386K 0.09% 177
2025
Q2 		$14M Sell
36,026
-2,681
-7% -$1.08M 0.12% 145
2025
Q1 		$16.8M Sell
38,707
-4,238
-10% -$1.7M 0.16% 104
2024
Q4 		$15.8M Buy
42,945
+839
+2% +$351K 0.14% 108
2024
Q3 		$21.9M Sell
42,106
-1,906
-4% -$1.02M 0.21% 76
2024
Q2 		$23.8M Sell
44,012
-168
-0.4% -$88.8K 0.24% 62
2024
Q1 		$22.9M Buy
44,180
+6,294
+17% +$3.13M 0.24% 69
2023
Q4 		$17.9M Buy
37,886
+2,476
+7% +$1.14M 0.21% 84
2023
Q3 		$15.4M Buy
35,410
+557
+2% +$253K 0.21% 81
2023
Q2 		$15.5M Sell
34,853
-4,632
-12% -$2.14M 0.21% 86
2023
Q1 		$18.2M Buy
39,485
+1,109
+3% +$528K 0.27% 67
2022
Q4 		$19.7M Buy
38,376
+3,496
+10% +$1.78M 0.32% 62
2022
Q3 		$15.8M Buy
34,880
+3,844
+12% +$1.84M 0.3% 56
2022
Q2 		$15M Buy
31,036
+14,287
+85% +$7.07M 0.3% 60
2022
Q1 		$8.23M Buy
16,749
+784
+5% +$358K 0.14% 126
2021
Q4 		$7.4M Buy
15,965
+3,567
+29% +$1.5M 0.12% 157
2021
Q3 		$4.62M Sell
12,398
-1,203
-9% -$457K 0.09% 194
2021
Q2 		$5.19M Sell
13,601
-3,527
-21% -$1.35M 0.1% 169
2021
Q1 		$6.15M Sell
17,128
-16,773
-49% -$5.39M 0.13% 141
2020
Q4 		$10.9M Sell
33,901
-272
-0.8% -$83.5K 0.24% 74
2020
Q3 		$9.18M Sell
34,173
-3,835
-10% -$1.03M 0.23% 88
2020
Q2 		$9.99M Buy
+38,008
New +$10.1M 0.26% 78

Other funds holding ELV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Sanders Capital
Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Xponance's ELV Position: Q2 2026 in Review

Xponance reduced its Elevance Health (ELV) stake by 0.5% in Q2 2026, selling an estimated $77.5K and leaving 41,309 shares worth $16M. The position accounts for 0.1% of the portfolio, ranked #166.

Xponance first reported a position in ELV in Q2 2020 and has held it in 25 quarters since. The position peaked at $23.8M in Q2 2024. 1,602 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Xponance held 41,309 shares of Elevance Health worth $16M as of Q2 2026.
  • Xponance sold 209 Elevance Health shares in Q2 2026, an estimated $77.5K.
  • Elevance Health made up 0.1% of Xponance's portfolio in Q2 2026, its #166 holding.
  • Xponance first reported a position in Elevance Health in Q2 2020 and has held it in 25 quarters since.
  • Xponance's Elevance Health position peaked at $23.8M in Q2 2024.
  • 1,602 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Xponance's 13F filing for Q2 2026, filed 10 Aug 2026.